Financial Reports
Related Searches:
Filter by:
July 24, 2008
Bristol-Myers Squibb
2Q Revenues: $5.2 billion (+16%)
2Q Earnings: $764.0 million (+8%)
YTD Revenues: $10.1 billion (+19%)
YTD Earnings: $1.4 billion (+2%)
Comments: Pharmaceutical sales in the quarter were $4.5 billion (+…
Read More »
July 23, 2008
Pfizer
2Q Revenues: $12.1 billion (+9%)
2Q Earnings: $2.8 billion (+119%)
YTD Revenues: $24.0 billion (+2%)
YTD Earnings: $5.6 billion (+19%)
Comments: Pharmaceutical sales in the quarter were $11.1 billion (+9%) and $22.0 billion YTD…
Read More »
July 23, 2008
Wyeth
2Q Revenues: $5.9 billion (+5%)
2Q Earnings: $1.1 billion (-6%)
YTD Revenues: $11.7 billion (+6%)
YTD Earnings: $2.3 billion (-5%)
Comments: Pharmaceutical sales were $5.0 billion (+5%), due to Effexor, Enbrel, Prev…
Read More »
July 23, 2008
Genzyme
2Q Revenues: $1.2 billion (+25%)
2Q Earnings: $69.6 million (-17%)
YTD Revenues: $2.3 billion (+25%)
YTD Earnings: $214.8 million (-11%)
Comments: Myozyme sales were up 65% in the quarter to $77.2 million. The company is still…
Read More »
July 22, 2008
Schering-Plough
2Q Revenues: $4.9 billion (+55%)
2Q Earnings: $436 million (-16%)
YTD Revenues: $9.6 billion (+56%)
YTD Earnings: $726 million (-34%)
Comments: Pharmaceutical sales were $3.7 billion in the quarter (+47%) and $7.3 billi…
Read More »
July 22, 2008
Merck
2Q Revenues: $6.1 billion (-1%)
2Q Earnings: $1.8 billion (+5%)
YTD Revenues: $11.9 billion (flat)
YTD Earnings: $5.1 billion (+50%)
Comments: Worldwide sales of Singulair were $1.1 billion in the quarter (-1%). Combined worldwid…
Read More »
July 22, 2008
Biogen Idec
2Q Revenues: $993 million (+28%)
2Q Earnings: $207 million (+11%)
YTD Revenues: $1.9 billion (+30%)
YTD Earnings: $369.7 million (+16%)
Comments: Growth in the quarter was driven by Avonex sales up 14% to $527 million, Tysa…
Read More »
July 21, 2008
Roche
1H08 Revenues: $21.5 billion (+4%)
1H08 Earnings: $5.6 billion (-2%)
Comments: Pharmaceutical sales were $16.8 billion (+3%). Oncology sales increased 15%, driven by Avastin (+36% to $2.3 billion), MabThera/Rituxan (+17% to $2.8…
Read More »
July 18, 2008
Gilead Sciences
2Q Revenues: $1.3 billion, (+22%)
2Q Earnings: $442.8 million (+9%)*
YTD Revenues: $2.5 billion (+22%)
YTD Earnings: $939.0 million (+15%)
Comments: Product sales were a record $1.2 billion in the quarter driven…
Read More »
July 17, 2008
Novartis
2Q Revenues: $10.7 billion (+14%)
2Q Earnings: $2.3 billion (+17%)
YTD Revenues: $20.6 billion (+11%)
YTD Earnings: $4.6 billion (+13%)
Comments: Pharmaceutical sales were $6.9 billion (+14%) in the quarter and $13.2 billion (…
Read More »
July 16, 2008
Abbott
2Q Revenues: $7.3 billion (+15%)
2Q Earnings: $1.3 billion (+34%)
YTD Revenues: $14.1 billion (+14%)
YTD Earnings: $2.3 billion (+34%)
Comments: Worldwide pharmaceutical sales increased 17% percent in the quarter to $4.1 billion…
Read More »
July 15, 2008
Johnson & Johnson
2Q Revenues: $16.5 billion (+9%)
2Q Earnings: $3.3 billion (+8%)
YTD Revenues: $32.6 billion (+8%)
YTD Earnings: $6.9 billion (+23%)
Comments: Pharmaceutical sales were $6.3 billion (+3%), driven by Topamax sales ($677…
Read More »
July 15, 2008
Genentech
2Q Revenues: $3.2 billion (+7%)
2Q Earnings: $782 million (+5%)
YTD Revenues: $6.3 billion (+7%)
YTD Earnings: $1.8 billion (+21%)
Comments: Rituxan sales were $651 million in the quarter (+12%). Avastin sales were $650 million (+…
Read More »
June 6, 2008
Patheon
2Q Revenues: $186 million (16%)
2Q Loss: $8.5 million (loss of $22 million in 2Q07)
YTD Revenues: $350 million (+14%)
YTD Loss: $23.7 million (loss of $24 million YTD07)
Comments: Commercial manufacturing revenues in the quarte…
Read More »
May 28, 2008
Pall Corp.
3Q Revenues: $661.7 million (+18%)
YTD Revenues: $1.8 billion (+15%)
Comments: In the quarter, life science sales were $253.0 million (+3%) with Medical sales of $124.6 million (-3%) and BioPharmaceuticals sales of $12…
Read More »
